The U.S. International Trade Commission has declined to stay the exclusion and cease-and-desist orders it imposed on cannabis vape manufacturer Stiiizy Inc., leaving an effective import and sales ban in place while the company pursues an appeal at the Federal Circuit. The ITC issued its denial on Friday without detailed explanation, rejecting Stiiizy's argument that enforcement should be paused during appellate review of what the company calls an unresolved legal question about patent eligibility standards. For a cannabis brand whose product line centers on vape hardware, the orders carry immediate commercial consequence.
What the Orders Actually Do - and Why Stiiizy Is Fighting Them
A limited exclusion order at the ITC blocks the importation of specific products found to infringe a U.S. patent. A cease-and-desist order goes further: it can prohibit domestic sale, advertising, and distribution of infringing inventory already inside the country. Together, those two instruments can effectively halt a hardware-dependent brand's commercial operations - not in some future regulatory scenario, but now.
The underlying dispute is with Pax Labs, which filed the original ITC complaint alleging Stiiizy's vape devices infringed its patents. The ITC sided with Pax Labs, and in a September 2025 affirmation upheld the administrative law judge's finding that Pax Labs had satisfied the domestic industry requirement - the legal threshold a complainant must clear to bring an ITC patent action. That's where things get complicated.
The domestic industry requirement has an economic prong, which typically asks whether the patent holder has made substantial investment in the exploitation of the patent in the United States. The contested question here is whether investments made before a patent is actually issued - pre-issuance investments - can count toward satisfying that prong. The ITC said yes. Stiiizy says that answer has never been tested at the Federal Circuit, making it a first-impression issue. That's not a trivial procedural complaint. First-impression rulings are precisely the kind of legal uncertainty that courts grant stays to address.
The Stay Standard - and Where Stiiizy's Argument Ran Into Trouble
To obtain a stay of ITC remedial orders, a moving party generally needs to show that the legal question at issue is at least debatable, and that the balance of harms favors pausing enforcement. Stiiizy made both arguments. On the legal question, the company pointed out that the ITC's own Office of Unfair Import Investigations and the original administrative law judge had initially concluded that pre-issuance investments should not count - before the ALJ reversed on remand after the full Commission found his first ruling categorically wrong. That internal disagreement, Stiiizy argued, is itself evidence that the question is difficult and unsettled.
On the balance of harms, Stiiizy argued that enforcement of the exclusion order would cause irreparable harm to its business - harm that could not be undone even if the company prevails at the Federal Circuit. The specifics were redacted in public filings, but the general shape of the risk isn't hard to read: a vape brand cut off from its hardware supply chain faces distribution collapse, retail partner attrition, and shelf-space loss that doesn't reverse when a court ruling comes down months or years later.
Stiiizy also argued that Pax Labs would not suffer equivalent harm from a stay, noting that most of Pax Labs' revenue comes from sources unrelated to the patents at issue. The ITC denied the stay anyway - and offered no detailed reasoning for doing so.
What This Means for Cannabis Brands Dependent on Hardware Supply Chains
Here's the thing about vape-focused cannabis brands: they operate with an inherent supply chain vulnerability that other product categories don't face in the same way. A flower SKU or a tincture line is largely a domestic manufacturing story. A vape device - the pod, the battery, the cartridge hardware - typically involves international component sourcing, which puts the entire business within reach of ITC jurisdiction the moment a patent dispute arises.
That's not a hypothetical risk. ITC exclusion orders move fast relative to federal district court patent litigation. The agency was designed to protect domestic industry from infringing imports, and it has broad authority to act quickly. For a cannabis company that has built its brand identity around a specific hardware format, an exclusion order isn't just a legal problem - it's an inventory, compliance, and retail operations problem simultaneously. Dispensary partners carrying that brand suddenly face SKU gaps, return questions, and wholesale menu adjustments.
What the Stiiizy case adds to that picture is a question about how aggressively the ITC will interpret the domestic industry requirement in future cannabis-adjacent patent cases. If pre-issuance investments count - and the Federal Circuit affirms that position - the pool of potential ITC complainants who can meet the domestic industry threshold gets wider. That has implications well beyond this particular dispute.
The Federal Circuit Has the Next Move
When Stiiizy brought its case to the Federal Circuit on March 24, it filed both an emergency stay motion and an immediate administrative stay request. The appellate court ordered the ITC to rule on its own pending motion by April 9 - which the ITC has now done, by denying it. The Federal Circuit must now decide whether to grant a stay on its own, allow enforcement to continue pending full appellate review, or chart some intermediate course.
The ITC's silence on its reasoning is notable. Courts reviewing agency decisions on stay motions expect some articulation of how the agency weighed the relevant factors. Whether the Federal Circuit treats that silence as a gap worth filling - or simply proceeds to its own independent stay analysis - will shape how quickly the orders take practical effect.
For Stiiizy, the clock is running. For other cannabis hardware brands watching this case, the lesson is the same one that comes up repeatedly in regulated cannabis business: intellectual property exposure in supply chains isn't a back-burner compliance issue. It belongs in the same risk assessment as license renewals, 280E tax treatment, and state-level packaging requirements. The ITC moves on its own timeline, and it doesn't pause for the cannabis industry's other complications.
